National Institute of Allergy and Infectious Diseases; Amended Notice of Meeting, 28704 [07-2539]

Download as PDF 28704 Federal Register / Vol. 72, No. 98 / Tuesday, May 22, 2007 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings jlentini on PROD1PC65 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, Comprehensive Minority Institution Cancer Center Partnership. Date: June 10–12, 2007. Time: 7 p.m. to 11 p.m. (June 10), 8 a.m. to 5 p.m. (June 11 and 12). Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Gerald G. Lovinger, PhD, Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8101, Bethesda, MD 20892–8329, 301–496–7897, lovingeg@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Clinical Studies Special Emphasis Panel. Date: June 18–19, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Majed M. Hamawy, PhD, MBA, Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8135, Bethesda, MD 20852, 301–594–5659, mh101v@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Cancer Sample Preparation/Detection and Diagnosis. Date: June 21, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD 20877. Contact Person: Lalita D. Palekar, PhD, Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer VerDate Aug<31>2005 19:44 May 21, 2007 Jkt 211001 Institute, 6116 Executive Blvd., Room 7141, Bethesda, MD 20892–7405, 301–496–7575, palekarl@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Innovations in Cancer Sample Preparation. Date: June 21, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD 20877. Contact Person: Lalita D. Palekar, PhD, Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 7141, Bethesda, MD 20892–7405, 301–496–7575, palekarl@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis (U01). Date: July 10–11, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Bethesda Suites, 6711 Democracy Blvd., Bethesda, MD 20817. Contact Person: C. Michael Kerwin, PhD, MPH, Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8057, Bethesda, MD 20892–8329, 301– 496–7421, kerwinm@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: May 15, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–2541 Filed 5–21–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of Allergy and Infectious Diseases Special Emphasis Panel, May 15, 2007, 1 p.m. to May 15, 2007, 4 p.m. National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Room 3258, Bethesda, MD 20817 which was published in the Federal Register on April 18, 2007, 72 FR 74, page 19546. PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 The meeting of the Special Emphasis Panel ZAI1 MMT M (S1), Tuberculosis Epidemiology, will be held on June 5, 2007, instead of May 15, 2007, at 1 p.m. and will end at 4 p.m. The meeting is closed to the public. Dated: May 16, 2007. Jennifer Spaeth, Director, Office of Special Advisory Committee Policy. [FR Doc. 07–2539 Filed 5–21–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Allergy, Immunology, and Transplantation Research Committee. Date: June 11, 2007. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW., Washington, DC 20007. Contact Person: Katrin Eichelberg, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 496–0818, keichelberg@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS). Dated: May 16, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–2540 Filed 5–21–07; 8:45 am] BILLING CODE 4140–01–M E:\FR\FM\22MYN1.SGM 22MYN1

Agencies

[Federal Register Volume 72, Number 98 (Tuesday, May 22, 2007)]
[Notices]
[Page 28704]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-2539]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Amended 
Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Institute of Allergy and Infectious Diseases Special Emphasis Panel, 
May 15, 2007, 1 p.m. to May 15, 2007, 4 p.m. National Institutes of 
Health, Rockledge 6700, 6700B Rockledge Drive, Room 3258, Bethesda, MD 
20817 which was published in the Federal Register on April 18, 2007, 72 
FR 74, page 19546.
    The meeting of the Special Emphasis Panel ZAI1 MMT M (S1), 
Tuberculosis Epidemiology, will be held on June 5, 2007, instead of May 
15, 2007, at 1 p.m. and will end at 4 p.m. The meeting is closed to the 
public.

    Dated: May 16, 2007.
Jennifer Spaeth,
Director, Office of Special Advisory Committee Policy.
[FR Doc. 07-2539 Filed 5-21-07; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.